These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13601120)

  • 1. Human fibrinolysis: a study of bacterial lipopolysaccharide induced and spontaneous fibrinolysis.
    COCHRAN B; WHITNEY EB; WARE AG
    Pharm Acta Helv; 1958; 33(8-10):719-25. PubMed ID: 13601120
    [No Abstract]   [Full Text] [Related]  

  • 2. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
    Varin R; Mirshahi S; Mirshahi P; Kierzek G; Sebaoun D; Mishal Z; Vannier JP; Yvonne Borg J; Simoneau G; Soria C; Soria J
    Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin and fibrinolysis in infection and host defense.
    Degen JL; Bugge TH; Goguen JD
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():24-31. PubMed ID: 17635705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion.
    Schoots IG; Levi M; van Vliet AK; Declerck PJ; Maas AM; van Gulik TM
    Thromb Haemost; 2004 Mar; 91(3):497-505. PubMed ID: 14983225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis.
    Pannell R; Kung W; Gurewich V
    J Thromb Haemost; 2007 May; 5(5):1047-54. PubMed ID: 17459007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations.
    Müller H; Renner M; Helmke BM; End C; Weiss C; Poeschl J; Mollenhauer J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):725-32. PubMed ID: 19698862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
    Binetti BM; Rotunno C; Tripodi A; Asti D; Semeraro F; Semeraro N; Colucci M
    Thromb Haemost; 2006 Apr; 95(4):606-11. PubMed ID: 16601829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.
    Ratel D; Mihoubi S; Beaulieu E; Durocher Y; Rivard GE; Gingras D; Béliveau R
    Thromb Res; 2007; 121(2):203-12. PubMed ID: 17512973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin affinity of erythrocyte-coupled tissue-type plasminogen activators endures hemodynamic forces and enhances fibrinolysis in vivo.
    Ganguly K; Goel MS; Krasik T; Bdeir K; Diamond SL; Cines DB; Muzykantov VR; Murciano JC
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1130-6. PubMed ID: 16284278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
    van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
    Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrin, fibrinolysis and arterosclerosis].
    HALSE T
    Med Welt; 1960 Aug; 33-34():1662-8. PubMed ID: 13710931
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
    Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage.
    Marchi R; López Ramirez Y; Nagaswami C; Masova L; Pulido A; López Mora J; Muller A; Arocha-Piñango CL; Weisel JW
    Thromb Haemost; 2007 Apr; 97(4):552-7. PubMed ID: 17393017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins.
    Gombás J; Tanka-Salamon A; Skopál J; Nagy Z; Machovich R; Kolev K
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):82-8. PubMed ID: 18180621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels.
    Smith JD; Chen A; Ernst LA; Waggoner AS; Campbell PG
    Bioconjug Chem; 2007; 18(3):695-701. PubMed ID: 17432824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.